252 related articles for article (PubMed ID: 7732379)
1. Oral immunization with a recombinant bacterial antigen produced in transgenic plants.
Haq TA; Mason HS; Clements JD; Arntzen CJ
Science; 1995 May; 268(5211):714-6. PubMed ID: 7732379
[TBL] [Abstract][Full Text] [Related]
2. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.
Mason HS; Haq TA; Clements JD; Arntzen CJ
Vaccine; 1998 Aug; 16(13):1336-43. PubMed ID: 9682399
[TBL] [Abstract][Full Text] [Related]
3. Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B.
Lauterslager TG; Florack DE; van der Wal TJ; Molthoff JW; Langeveld JP; Bosch D; Boersma WJ; Hilgers LA
Vaccine; 2001 Mar; 19(17-19):2749-55. PubMed ID: 11257419
[TBL] [Abstract][Full Text] [Related]
4. Development of mucosal protection against the heat-stable enterotoxin (ST) of Escherichia coli by oral immunization with a genetic fusion delivered by a bacterial vector.
Cárdenas L; Clements JD
Infect Immun; 1993 Nov; 61(11):4629-36. PubMed ID: 8406860
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous oral immunization of mice with live attenuated Escherichia coli expressing LT192-STa 13 and LT 192-STb fusion immunogen, respectively, for polyvalent vaccine candidate.
Liu W; Li J; Bao J; Li X; Guan W; Yuan C; Tang J; Zhao Z; Shi D
Appl Microbiol Biotechnol; 2015 May; 99(9):3981-92. PubMed ID: 25549617
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections.
Dale JB; Chiang EC
J Infect Dis; 1995 Apr; 171(4):1038-41. PubMed ID: 7706785
[TBL] [Abstract][Full Text] [Related]
7. Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein.
Wu CM; Chung TC
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):354-65. PubMed ID: 17651125
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs.
Chia MY; Hsiao SH; Chan HT; Do YY; Huang PL; Chang HW; Tsai YC; Lin CM; Pang VF; Jeng CR
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):215-25. PubMed ID: 21277027
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutant Escherichia coli heat-labile toxin in chickens.
Miller T; Fanton M; Nickelson S; Mason H; Webb S
Avian Pathol; 2012 Oct; 41(5):441-9. PubMed ID: 22928883
[TBL] [Abstract][Full Text] [Related]
10. Recombinant enterotoxins as vaccines against Escherichia coli-mediated diarrhoea.
Aitken R; Hirst TR
Vaccine; 1993; 11(2):227-33. PubMed ID: 8438620
[TBL] [Abstract][Full Text] [Related]
11. Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins.
Clements JD
Infect Immun; 1990 May; 58(5):1159-66. PubMed ID: 2182535
[TBL] [Abstract][Full Text] [Related]
12. A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT).
Chikwamba R; Cunnick J; Hathaway D; McMurray J; Mason H; Wang K
Transgenic Res; 2002 Oct; 11(5):479-93. PubMed ID: 12437079
[TBL] [Abstract][Full Text] [Related]
13. A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice.
Conceição FR; Moreira AN; Dellagostin OA
Vaccine; 2006 Jul; 24(29-30):5734-43. PubMed ID: 16730864
[TBL] [Abstract][Full Text] [Related]
14. Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants.
Rosales-Mendoza S; Alpuche-Solís AG; Soria-Guerra RE; Moreno-Fierros L; Martínez-González L; Herrera-Díaz A; Korban SS
Plant J; 2009 Jan; 57(1):45-54. PubMed ID: 18764920
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.
Tacket CO; Mason HS; Losonsky G; Clements JD; Levine MM; Arntzen CJ
Nat Med; 1998 May; 4(5):607-9. PubMed ID: 9585236
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins.
Jagusztyn-Krynicka EK; Clark-Curtiss JE; Curtiss R
Infect Immun; 1993 Mar; 61(3):1004-15. PubMed ID: 8432584
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen.
Lipscombe M; Charles IG; Roberts M; Dougan G; Tite J; Fairweather NF
Mol Microbiol; 1991 Jun; 5(6):1385-92. PubMed ID: 1724057
[TBL] [Abstract][Full Text] [Related]
18. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin.
Bost KL; Clements JD
Infect Immun; 1995 Mar; 63(3):1076-83. PubMed ID: 7868230
[TBL] [Abstract][Full Text] [Related]
19. Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus.
Kim TG; Kim BG; Kim MY; Choi JK; Jung ES; Yang MS
Mol Biotechnol; 2010 Jan; 44(1):14-21. PubMed ID: 19657748
[TBL] [Abstract][Full Text] [Related]
20. In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice.
Bost KL; Holton RH; Cain TK; Clements JD
Immunology; 1996 Apr; 87(4):633-41. PubMed ID: 8675220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
